glp-1 agonists cardiovascular diseases Frontiers Cardiovascular Protective Properties of GLP-1
Description
Diabetes Care 2010;33:951957
Most patients start with a lower dose that gradually increases over several weeks to minimize side effects
While these studies show the efficacy of these drugs, its still not clear whether the weight lost through GLP-1 drugs consists of fat, muscle or both
Weight-loss surgery effectively reduces weight and complications in patients with severe obesity
